Dj Officer Gleason Sells 4250 Of Criteo Sa >Crto

European equities traded in the US as American depositary receipts were tracking sharply lower late Tuesday morning, declining 1.71% to 1,313.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS and biopharmaceutical company Cellectis , which rose 4.4% and 1.1% respectively. They were followed by accommodations booking platform trivago , which rose 0.6%.

The decliners from continental Europe were led by biotech firm Evaxion Biotech and biopharmaceutical company DBV Technologies , which fell 1.7% and 3.7% respectively. They were followed by oil and gas company TotalEnergies and pharmaceutical company Novo Nordisk (NVO), which dropped 3.2% and 2.6% respectively.

From the UK and Ireland, the gainers were led by software firm Endava and biopharmaceutical company Biodexa Pharmaceuticals B, which advanced 7.4% and 2.5% respectively. They were followed by biopharmaceutical companies NuCana and TC Biopharm , which increased 2% and 1.9% respectively.

The decliners from the UK and Ireland were led by telecommunications operator Vodafone Group and biopharmaceutical company Mereo BioPharma Group , which lost 7.9% and 5.1% respectively. They were followed by insurance firm Prudential and pharmaceutical Silence Therapeutics , which dropped 5% and 4% respectively.

European equities traded in the US as American depositary receipts were moving higher late Monday morning, rising 0.35% to 1,339.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet browser company Opera and pharmaceutical company Ascendis Pharma , which rose 4.8% and 3.3% respectively. They were followed by pharmaceutical company Novo Nordisk and internet advertising firm Criteo , which were up 2.9% and 2% respectively.

The decliners from continental Europe were led by accommodations booking company trivago and biotech firm Evaxion Biotech , which fell 2.4% and 1.8% respectively. They were followed by medical device maker Edap and telecommunications operator Telefonica , which were down 1.7% and 1.6% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana and Akari Therapeutics , which climbed 6.3% and 5.2% respectively. They were followed by financial services company Barclays and software firm Endava , which increased 3.6% and 2.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm and biotech firm Trinity Biotech , which lost 5.9% and 3.7% respectively. They were followed by mining company BHP Group and biopharmaceutical company Amarin , which were off 2.8% and 2.1% respectively.

European equities traded in the US as American depositary receipts started the week tracking higher late Monday morning, rising 0.49% to 1,366.51 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies and internet advertising firm Criteo , which rose 4.4% and 4.8% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria and tech conglomerate Philips , which increased 3% and 2.7% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS and pharmaceutical company Novo Nordisk , which fell 5.1% and 1.6% respectively. They were followed by 3D printer company Materialise and biotech firm BioNTech , which were down 1.6% and 1.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics and Bicycle Therapeutics , which were up 5.9% and 4.2% respectively. They were followed by biopharmaceutical companies Amarin and NuCana , which rose 2.8% and 2.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics and Biodexa Pharmaceuticals B, which lost 5.3% and 1.9% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group and biotech firm Trinity Biotech 2.4% and 2.3% respectively.

European equities traded in the US as American depositary receipts were rallying late Friday morning, rising 0.98% to 1,367.20 on the S&P Europe Select ADR Index, but were still down 1.4% for the week.

From continental Europe, the gainers were led by biopharmaceutical company Genfit and semiconductor company Sequans Communications , which rose 5.8% and 3.3%, respectively. They were followed by financial services companies Banco Santander and Banco Bilbao Vizcaya Argentaria , which were up 2.4% and 2.1%, respectively.

The decliners from continental Europe were led by furniture maker Natuzzi and biotech firm BioNTech , which fell 4.7% and 1.4%, respectively. They were followed by biotech firm Evaxion Biotech and internet advertising firm Criteo , which were off 0.8% and 0.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics and pharmaceutical company Silence Therapeutics , which increased 5.4% and 3.6%, respectively. They were followed by financial services company Lloyds Banking Group and biopharmaceutical company Amarin Corporation , which rose 2.9% and 2.8%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech , which fell 3.4%, followed by biopharmaceutical company Akari Therapeutics and cruise line operator Carnival were off 0.2% and 0.1%, respectively.